Accelerating clinical research as study complexity grows
How early planning and a unified data platform can cut trial timelines and costs
Add bookmark
The complexity of clinical trials has grown dramatically in recent years as the number of procedures performed per patient in Phase III trials increases. The jump in the number of procedures has led to a rapid growth in the data created by and required for developing modern therapies.
Combined with longstanding patient recruitment challenges, traditional clinical trial approaches have become overwhelmed, as complex trials take longer to run. The cost of longer therapy development timelines can prove too high for both patients and companies working in the field.
By using a flexible, scalable unified interface, powerful analytics and user-friendly technology to reduce total study timelines and the number of protocol amendments, pharma companies can cut trial timelines and reduce costs.
This report addresses pain points such as patient enrollment, site recruitment and retention, and data clean-up, and explains why solving the IT and platform integration problems can address compliance and regulatory concerns, as well as data and performance issues that could further delay trials.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Download this white paper from Medidata to learn:
- What the ideal data platform for accelerating clinical trials looks like.
- Why a flexible and unified trial platform can help relieve major clinical trial pain points.
- How to address complex and costly patient enrollment trial challenges through an integrated feasibility process.
